Skip to main content

Table 6 Subgroup analysis of changes in fibrosis scores

From: Evaluation of long-term changes of aspartate—platelet ratio index, FIB4, and liver stiffness in chronic hepatitis C patients successfully treated by direct-acting antivirals

Baseline TE

LSM

APRI

FIB4

Baseline

Follow-up

P value

Baseline

Follow-up

P value

Baseline

Follow-up

P value

F0

4.34±0.7

5.05±2.4

0.19

0.46±0.34

0.24±0.13

0.004

1±0.6

0.9±0.6

0.5

F1

6 ± 0.4

5 ± 1.2

<0.001

0.4±0.3

0.26±0.1

0.006

1.1±0.8

0.98±0.5

0.37

F2

8.1±0.8

6.9±3

0.15

0.48±0.2

0.2±0.1

0.001

1.15±0.5

0.95±0.5

0.13

F3

11±0.8

8.5±2

0.02

0.78±0.7

0.3±0.1

0.06

1.47±0.8

0.95±0.4

0.08

F4

21±8.6

18.5±7.5

0.14

0.86±0.5

0.4±0.25

<0.001

3.3±2.5

2±1.5

0.01